Why is the target price for slrx over 7.00

The target price for SLRX (Salarius Pharmaceuticals) is set at $26.00, which is significantly higher than the current closing price of $3.50. Here's why:

1. Analyst Consensus: The average target price is based on analyst consensus, which indicates that analysts believe the stock has potential for growth. In this case, the average target price is $26.00.
2. Recent Developments: Salarius Pharmaceuticals has recently experienced significant developments that could impact its stock price. Notably, the company has entered into an ATM offering with Ladenburg Thalmann, which could potentially raise up to $810,973 in additional capital. This financial lifeline could be seen as a positive step towards supporting the company's therapeutic goals and potentially increasing its value.
3. Market Potential: The broader genomics sector is expected to grow at a compound annual growth rate (CAGR) of 16.5% from 2024 to 2030, with an estimated market size of $94.86 billion by the forecast culmination point. As a company specializing in gene dysregulation therapeutic research, Salarius could benefit from this growth trend.
4. Investor Speculation: Despite the current market capitalization being under $2 million, the potential influx of nearly $1 million could significantly impact the stock's value due to its modest valuation. Additionally, the fear of missing out (FOMO) among investors could drive prices higher in anticipation of a strategic alternative being pursued by the company.
5. Intrinsic Value: The intrinsic valuation of Salarius Pharmaceuticals suggests a higher potential for growth, with a low real high estimate of $16.56. This indicates that analysts believe the stock has the potential to reach a higher value based on its fundamentals.

In conclusion, the target price for SLRX is set at $26.00 due to positive analyst sentiment, recent company developments, growth potential in the genomics market, investor speculation, and the intrinsic value of the company. These factors combined suggest that the stock has the potential to significantly increase in value from its current price.